Acute pulmonary embolism in times of SARS-CoV-2 : Diagnostic and therapeutic management
There is a clear association between novel coronavirus 2 infection and the diagnosis of venous thromboembolic disease, as a cosequence of the development of a systemic inflammatory response syndrome due to the activation of the coagulation cascade. It occurs in 90% of patients with severe forms of the infection, evidencing the presence of pulmonary endovascular micro and macro thrombosis. This suggests a possible clinical benefit of thromboprophylaxis according to the patient’s clinical risk. The suspicion of venous thromboembolic disease in the context of this pandemic represents a diagnostic challenge due to the co-existence of similarities between both conditions in several different aspects. It should be noted that the diagnosis of acute pulmonary embolism does not exclude the possibility of simultaneous viral infection. The evaluation of patients with suspected acute pulmonary embolism in the context of the pandemic should be optimized in order to implement a rapid diagnosis and treatment to reduce the associated morbidity and mortality. This will help reducing infectious risk for health-care professionals and other patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:91 |
|---|---|
| Enthalten in: |
Archivos de cardiologia de Mexico - 91(2021), Suplemento COVID vom: 20. Dez., Seite 055-063 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Tromboembolismo pulmonar agudo en tiempos de SARS-CoV-2: diagnóstico y tratamiento |
|---|
| Beteiligte Personen: |
Scatularo, Cristhian E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticoagulants |
|---|
| Anmerkungen: |
Date Completed 02.02.2022 Date Revised 08.05.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.24875/ACM.20000251 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320223310 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320223310 | ||
| 003 | DE-627 | ||
| 005 | 20231225173122.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.24875/ACM.20000251 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1067.xml |
| 035 | |a (DE-627)NLM320223310 | ||
| 035 | |a (NLM)33459725 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Scatularo, Cristhian E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Acute pulmonary embolism in times of SARS-CoV-2 |b Diagnostic and therapeutic management |
| 246 | 3 | 3 | |a Tromboembolismo pulmonar agudo en tiempos de SARS-CoV-2: diagnóstico y tratamiento |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.02.2022 | ||
| 500 | |a Date Revised 08.05.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a There is a clear association between novel coronavirus 2 infection and the diagnosis of venous thromboembolic disease, as a cosequence of the development of a systemic inflammatory response syndrome due to the activation of the coagulation cascade. It occurs in 90% of patients with severe forms of the infection, evidencing the presence of pulmonary endovascular micro and macro thrombosis. This suggests a possible clinical benefit of thromboprophylaxis according to the patient’s clinical risk. The suspicion of venous thromboembolic disease in the context of this pandemic represents a diagnostic challenge due to the co-existence of similarities between both conditions in several different aspects. It should be noted that the diagnosis of acute pulmonary embolism does not exclude the possibility of simultaneous viral infection. The evaluation of patients with suspected acute pulmonary embolism in the context of the pandemic should be optimized in order to implement a rapid diagnosis and treatment to reduce the associated morbidity and mortality. This will help reducing infectious risk for health-care professionals and other patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Embolia pulmonar | |
| 650 | 4 | |a Infecciones por coronavirus | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Trombosis | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 700 | 1 | |a Farina, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Cigalini, Ignacio M |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez, Gonzalo |e verfasserin |4 aut | |
| 700 | 1 | |a Wyss, Fernando S |e verfasserin |4 aut | |
| 700 | 1 | |a Saldarriaga, Clara |e verfasserin |4 aut | |
| 700 | 1 | |a Baranchuk, Adrián |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archivos de cardiologia de Mexico |d 2001 |g 91(2021), Suplemento COVID vom: 20. Dez., Seite 055-063 |w (DE-627)NLM114616272 |x 1665-1731 |7 nnns |
| 773 | 1 | 8 | |g volume:91 |g year:2021 |g number:Suplemento COVID |g day:20 |g month:12 |g pages:055-063 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.24875/ACM.20000251 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 91 |j 2021 |e Suplemento COVID |b 20 |c 12 |h 055-063 | ||